Efficacy of Amantadine Treatment in COVID-19 Patients

NCT04952519 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

193

Enrollment

INDUSTRY

Sponsor class

Stopped The annual analysis did not show the efficacy of the investigational medicinal product in this application, therefore the study was not continued.

Conditions

Patients With Moderate or Severe COVID-19

Interventions

DRUG: Amantadine

Sponsor

Noblewell

Collaborators

[object Object]
[object Object]